Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pha Co. Ltd. (043370:KRX), powered by AI.
Pha Co. Ltd. is currently trading at ₩13,060. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Pha Co. Ltd. on Alpha Lenz.
Pha Co. Ltd.'s P/E ratio is 5.9.
“Pha Co. Ltd. trades at a P/E of 5.9 (undervalued) with modest ROE of 5.6%.”
Ask for details →Pha Co. Ltd. operates as a dynamic force within the pharmaceutical industry, specializing in the production and distribution of a comprehensive range of medicinal products. The primary function of Pha Co. Ltd. is to enhance healthcare solutions by developing pharmaceuticals that cater to various medical needs, from chronic conditions to acute therapies. Notably, the company engages in rigorous research and development efforts to innovate and improve drug formulations, ensuring compliance with international quality standards. Its impact spans across multiple sectors, including hospitals, clinics, and pharmacies, contributing significantly to the healthcare infrastructure. The market significance of Pha Co. Ltd. is underscored by its commitment to safety, efficacy, and accessibility, bolstering public health initiatives. As it continues to expand its portfolio and global reach, Pha Co. Ltd. plays a crucial role in addressing both existing and emerging healthcare challenges.
“Pha Co. Ltd. trades at a P/E of 5.9 (undervalued) with modest ROE of 5.6%.”
Ask for details →Pha Co. Ltd. (ticker: 043370) is a company listed on KRX in the Consumer Cyclical sector (Auto Parts). It has approximately 642 employees. Market cap is $274.3B.
The current price is ₩13,060 with a P/E ratio of 5.93x and P/B of 0.32x.
ROE is 5.63% and operating margin is 4.03%. Annual revenue is $1.2T.